Doctors’ Attitudes Towards E-Cigarettes: A Study in the US

Apr.16.2022
Electronic cigarettes may help smokers quit, but only 22% of US doctors recommend them, according to a study.

In the United States, approximately 480,000 people die from smoking each year. Despite the fact that the US Food and Drug Administration (FDA) has not yet approved electronic cigarettes as a smoking cessation device, many people ask their doctors whether using e-cigarettes can be a substitute for tobacco cigarettes or a way to help them quit smoking. E-cigarettes work by heating a liquid that contains nicotine.

 

According to Michael Steinberg, the Director of the Tobacco Dependence Program at Rutgers University's Tobacco Research Center and Chairman of the Department of Medicine at Rutgers Robert Wood Johnson Medical School, who is also the author of a research report, "As more and more evidence shows that electronic cigarettes may be effective for smoking cessation, they may play a key role in reducing cigarette usage and subsequent tobacco-related diseases. Understanding doctors' views on e-cigarettes as a harm-reduction tool is important.

 

This study, published in the online version of the Journal of the American Medical Association, surveyed 2,058 American doctors in 2018 and again in 2019 on their communication with patients about electronic cigarettes. Researchers asked how they would advise two different patients who want to quit smoking: a young woman with a mild addiction who has not yet attempted to quit, and an older man with a severe addiction who has tried multiple methods to quit in the past.

 

Only 22% of the surveyed doctors reported recommending e-cigarettes to their patients, with 10% stating they had done so within the 30 days prior to completing the questionnaire.

 

A recent study has found that doctors are three times more likely to recommend e-cigarettes to heavy smokers who have previously failed to quit smoking. Typically, doctors recommend FDA-approved medication such as nicotine gum or lozenges for mild smokers. Nearly 70% of doctors reported that their patients have asked them questions about e-cigarettes, with one-third saying they were asked within the past 30 days. More than 60% of doctors mistakenly believe that all tobacco products are equally harmful.

 

Cristine Delnevo, director of the Tobacco Research Center at Rutgers University and a professor of Health Behavior, Society and Policy at Rutgers School of Public Health, said, "These findings suggest that it is crucial to address doctors' misconceptions and educate them on the effectiveness of e-cigarettes, particularly in correcting the erroneous belief that all tobacco products are equally harmful, when in fact, combusted tobacco is by far the most dangerous.

 

The study also found that pulmonologists, cardiologists, and physicians who follow the clinical practice guidelines of the US Public Health Service for treating tobacco use and addiction are more likely to recommend e-cigarettes to patients, as well as those who hold harm reduction views and have a history of smoking themselves. However, if patients inquire about e-cigarettes first, physicians are also more likely to recommend them.

 

Source: Cnbeta

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
The Texas Supreme Court issued a case summary on May 8, 2026, describing its decision in Hancock v. RJR Vapor Co. LLC. The dispute centered on whether RJR Vapor’s VELO oral nicotine pouches are taxable as “tobacco products” under the Texas Tax Code. Lower courts had held that the pouches were not taxable tobacco products, but the Texas Supreme Court reversed, concluding that VELO pouches are taxable because they are made of “a tobacco substitute.”
May.09 by 2FIRSTS.ai
    Shenzhen Tobacco Monopoly Bureau Moves to Advance E-Cigarette Regulatory System 2.0
Shenzhen Tobacco Monopoly Bureau Moves to Advance E-Cigarette Regulatory System 2.0
The Shenzhen Tobacco Monopoly Bureau recently held the city’s 2026 e-cigarette regulation work conference to implement higher-level meeting requirements, review the city’s e-cigarette regulatory work in 2025 and during the 14th Five-Year Plan period, assess the current situation, and deploy the rollout of E-cigarette Regulatory System 2.0 across Shenzhen’s tobacco commercial system.
Apr.28 by 2FIRSTS.ai
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
The show had become an important check-in point for Chinese manufacturers and brand owners looking for signs of change in the U.S. market after months of softer demand. Instead, participants said the event highlighted a more restrained mood: traffic in the vape section was uneven, standout launches were limited, and conversations often failed to turn into orders.
Special Report
Apr.12
Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand
Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand
Philip Morris International said its Swedish Match facility in Owensboro will adjust part of its production schedule this summer in response to changing market conditions. According to a notice the company gave union leadership and employees on April 22, parts of ZYN production will shift from a 24/7 schedule back to a 24/5 schedule. The ZYN Flagship department will return to a five-day, three-shift operation.
Apr.23 by 2FIRSTS.ai
Product | Labeled “Built in the USA” + 33mL Total E-Liquid, iJOY XP100K E-Cigarette Launched in the U.S.
Product | Labeled “Built in the USA” + 33mL Total E-Liquid, iJOY XP100K E-Cigarette Launched in the U.S.
iJOY Launches New IJOY XP100K E-Cigarette on Official Website. The product adopts a combined structure of “pod + power bank + refill e-liquid bottle,” comes pre-filled with 18mL of e-liquid and includes 15mL of refill liquid. It is officially claimed to deliver up to approximately 100,000 puffs, and its packaging bears the wording “BUILT IN THE USA.” It has already gone on sale through some online channels in the United States, with the kit priced at US$19.99.
Apr.08 by 2FIRSTS.ai
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Ahead of World No Tobacco Day, a Nature Health Comment by Robert Beaglehole, Ruth Bonita and Tikki Pang argues that regulated smoke-free nicotine products could help accelerate the global decline in smoking. The authors propose a “smoke-free 2040” goal and call for risk-proportionate regulation distinguishing cigarettes from lower-risk nicotine alternatives.
News
May.20